Experts allay Covaxin concerns, say 50% effectiveness against Delta-driven Covid surge not bad

The results of the first real-world assessment of Covaxin published in The Lancet Infectious Diseases journal

from The Hindu - Coronavirus https://ift.tt/3xk9UBX
https://ift.tt/eA8V8J